- 2023 Multidisciplinary Oncology Review
- 2022
- Videos
- 2021
- 2020
- 2019
- Hematology & Medical Oncology Review 2019
- 2018
- Events
Playback speed
10 seconds
52 y/o With HER2+/HR- De-novo Metastatic BC / 52 y/o With T2N0 HR+/HER2- Grade II IDC
0 views
March 12, 2020
Comments 0
Login to view comments.
Click here to Login
2019 Post San Antonio Breast Cancer Review